King Legacy, a wholly owned subsidiary of Pfizer recalls

11 recalls on record

Recalls filed with 1 agency: FDA (11).

First recall on record: May 29, 2013. Most recent: May 29, 2013.

Risk classification: Class II: 11

Recalert records 11 recalls for King Legacy, a wholly owned subsidiary of Pfizer from FDA. The earliest is dated May 29, 2013 and the latest May 29, 2013. 0 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles (NDC 60793-853-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620 (D-424-2013).

Most recent recalls

Questions about this company

Does King Legacy, a wholly owned subsidiary of Pfizer have recalls in 2026?
Recalert records 0 recalls for King Legacy, a wholly owned subsidiary of Pfizer dated in 2026.
How do I check if my King Legacy, a wholly owned subsidiary of Pfizer product is recalled?
Compare the product, model, lot or UPC with the official notices. Check your inventory free on Recalert.

Do you carry products from King Legacy, a wholly owned subsidiary of Pfizer? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies